Monday, Vanda Pharmaceuticals Inc. (VNDA) said its third-quarter net loss narrowed to $7.72 million from $10.86 million in the prior year period.
Net loss per share attributable to common stockholders for the quarter also narrowed to $0.28 from $0.41 in the year-ago period. On average, 2 analysts polled by Thomson Reuters expected the company to report a loss of $0.31 per share for the quarter.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.